Manager activity
DAFNA Capital Management LLC
Nathan Fischel
New
17
Add
17
Reduce
26
Exit
11
71 shown
| ticker | action | Δ weight | detail | period |
|---|---|---|---|---|
| ASND | New | +2.47% | opened 2.5% | Q1→Q2 |
| KYMR | New | +0.59% | opened 0.59% | Q1→Q2 |
| ANL | New | +0.53% | opened 0.53% | Q1→Q2 |
| NGEN | New | +0.41% | opened 0.41% | Q1→Q2 |
| RNA | New | +0.33% | opened 0.33% | Q1→Q2 |
| DSGN | New | +0.28% | opened 0.28% | Q1→Q2 |
| Eupraxia Pharmaceutic… | New | +0.28% | opened 0.28% | Q1→Q2 |
| CRBP | New | +0.19% | opened 0.19% | Q1→Q2 |
| SEG | New | +0.13% | opened 0.13% | Q1→Q2 |
| ARTV | New | +0.12% | opened 0.12% | Q1→Q2 |
| EDIT | New | +0.11% | opened 0.11% | Q1→Q2 |
| Scynexis | New | +0.11% | opened 0.11% | Q1→Q2 |
| QTTB | New | +0.08% | opened 0.08% | Q1→Q2 |
| Nuvectis Pharma | New | +0.07% | opened 0.07% | Q1→Q2 |
| Tenaya Therapeutics | New | +0.04% | opened 0.04% | Q1→Q2 |
| Engene Therapeutics | New | +0.02% | opened 0.02% | Q1→Q2 |
| Kardigan | New | +0.02% | opened 0.02% | Q1→Q2 |
| DAWNGBX | Exit | −4.77% | was 4.8% | Q1→Q2 |
| Kalvista Pharmaceutic… | Exit | −1.22% | was 1.2% | Q1→Q2 |
| ASND | Exit | −1.21% | was 1.2% | Q1→Q2 |
| FULC | Exit | −0.36% | was 0.36% | Q1→Q2 |
| Engene | Exit | −0.29% | was 0.29% | Q1→Q2 |
| SCYXEUR | Exit | −0.23% | was 0.23% | Q1→Q2 |
| ORIC | Exit | −0.22% | was 0.22% | Q1→Q2 |
| ZBIO | Exit | −0.19% | was 0.19% | Q1→Q2 |
| NAMS | Exit | −0.15% | was 0.15% | Q1→Q2 |
| KPTI | Exit | −0.06% | was 0.06% | Q1→Q2 |
| NMRA | Exit | −0.03% | was 0.03% | Q1→Q2 |
| DNLI | Add | +2.23% | +132.0% sh | Q1→Q2 |
| NKTR | Add | +1.54% | +92.7% sh | Q1→Q2 |
| PODD | Add | +1.28% | +469.2% sh | Q1→Q2 |
| EWTX | Add | +0.95% | +102.1% sh | Q1→Q2 |
| KIDS | Add | +0.34% | +97.7% sh | Q1→Q2 |
| NGNE | Add | +0.27% | +57.2% sh | Q1→Q2 |
| SNDX | Add | +0.24% | +54.2% sh | Q1→Q2 |
| ANNX | Add | +0.18% | +152.8% sh | Q1→Q2 |
| AQST | Add | +0.16% | +75.3% sh | Q1→Q2 |
| MAZE | Add | +0.13% | +85.7% sh | Q1→Q2 |
| CYBN | Add | +0.10% | +3.2% sh | Q1→Q2 |
| IDYA | Add | −0.08% | +4.3% sh | Q1→Q2 |
| CTMX | Add | +0.07% | +90.6% sh | Q1→Q2 |
| ADCT | Add | −0.05% | +6.9% sh | Q1→Q2 |
| ALLO | Add | +0.03% | +46.0% sh | Q1→Q2 |
| MLYS | Add | −0.01% | +15.6% sh | Q1→Q2 |
| SPRY | Add | 0.00% | +17.9% sh | Q1→Q2 |
| RVMD | Reduce | +7.25% | −3.1% sh | Q1→Q2 |
| XBI | Reduce | −3.32% | −38.3% sh | Q1→Q2 |
| CMPS | Reduce | +2.39% | −16.8% sh | Q1→Q2 |
| BHVN | Reduce | −1.24% | −83.7% sh | Q1→Q2 |
| MBX | Reduce | −1.07% | −93.3% sh | Q1→Q2 |
| LRMR | Reduce | −0.91% | −1.0% sh | Q1→Q2 |
| NDAQ | Reduce | −0.84% | −31.4% sh | Q1→Q2 |
| CYTK | Reduce | −0.47% | −20.9% sh | Q1→Q2 |
| RCUS | Reduce | +0.42% | −0.5% sh | Q1→Q2 |
| BCAX | Reduce | −0.29% | −32.4% sh | Q1→Q2 |
| Immatics NV | Reduce | −0.28% | −48.2% sh | Q1→Q2 |
| NBIX | Reduce | −0.26% | −18.2% sh | Q1→Q2 |
| IMVT | Reduce | +0.25% | −0.7% sh | Q1→Q2 |
| KURA | Reduce | −0.18% | −48.9% sh | Q1→Q2 |
| BCRX | Reduce | −0.17% | −7.0% sh | Q1→Q2 |
| VRCA | Reduce | −0.16% | −84.5% sh | Q1→Q2 |
| ALGN | Reduce | −0.13% | −6.7% sh | Q1→Q2 |
| IPSC | Reduce | −0.13% | −1.4% sh | Q1→Q2 |
| FATE | Reduce | +0.12% | −4.5% sh | Q1→Q2 |
| ALKS | Reduce | −0.11% | −27.4% sh | Q1→Q2 |
| PROF | Reduce | −0.06% | −1.0% sh | Q1→Q2 |
| Compugen | Reduce | −0.06% | −34.7% sh | Q1→Q2 |
| AXGN | Reduce | −0.04% | −16.4% sh | Q1→Q2 |
| IBIO | Reduce | −0.03% | −12.2% sh | Q1→Q2 |
| PRQR | Reduce | −0.03% | −2.4% sh | Q1→Q2 |
| RARE | Reduce | +0.01% | −22.9% sh | Q1→Q2 |